Ortho Clinical Diagnostics
100 Indigo Creek Drive
73 articles with Ortho Clinical Diagnostics
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that ORTHO™ Sera, a suite of extended antigen phenotyping, has been cleared by the U.S. Food and Drug Administration for use on the ORTHO VISION® Analyzer.
Ortho Clinical Diagnostics Expands Drugs of Abuse and Therapeutic Drug Assay Menus in Collaboration With Thermo Fisher Scientific
New MicroTip Partnership Assays (MPAs) Help Detect the Use of Fentanyl and Tricyclic Antidepressants (TCA)
Ortho Clinical Diagnostics to Demonstrate How Data Management Can Empower Labs During AABB Annual Meeting and Special Customer Event at Historic Sunset Station
In Addition, Ortho to Celebrate 1,000 ORTHO VISION® Analyzers Installed in US Labs
Current Chairman and CEO Robert Yates to Step Down as CEO
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that, for the fourth consecutive year, its Ortho Care™ service and support program was ranked No. 1 in the diagnostics industry.
Ortho to Share Research on Precision and Quality in Groundbreaking Lab Technology, Infectious Disease and Endocrinology at AACC 2019
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it will present four scientific posters and co-sponsor two posters at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo.
Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced the CE Mark of an enhanced version of its VITROS® NT-proBNP II assay, part of Ortho's expansive cardiac menu
Ortho Clinical Diagnostics, Lab Leaders, Executives to Examine How Data Is Transforming Labs and Health Care
Ortho to Host Industry Conferences: 'Lab Leader Summit' and 'Healthcare Management in a Digital World'
Ortho Clinical Diagnostics to Present Research on Advances in Cardiac Testing, Diagnostics Technology at EuroMedLab 2019
Educational Workshop and Posters to Focus on High-Sensitivity Troponin Assay Use and Performance, Lab Technology Innovations
2-Day Summit Will Bring Together Top Hospital Executives and Focus on Patient Safety and Service Excellence
Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries
Next-generation assay aids in diagnosing heart attacks faster and more accurately, and is enabled on the company's newest analyzer, the VITROS® XT 7600 Integrated System
Groundbreaking XT MicroSlides Deliver Accurate Results from 2 Simultaneous Miniaturized Tests, Simplifying Workflow and Improving Turnaround Time in the Lab
Ortho Clinical Diagnostics and Leadman Biochemistry Introduce New MicroTip Partnership Assays in China
Launch of New MicroTip Partnership Assays (MPA) Enable a Broader Menu Offering in China for Renal, Liver and Cardiac Testing in the STAT Lab
Ortho Clinical Diagnostics' VITROS® XT MicroSlide Receives CE Mark, Is Submitted to FDA: First Multi-test Capability Added to Proprietary MicroSlide Technology
Groundbreaking Technology Delivers Accurate Results Clinicians Rely On and Trust While Simplifying Workflow and Improving Turnaround Time
Ortho Care™ Recognized for Its Ability to Anticipate Customer Needs in Hospitals, Labs and Blood Banks Around the World
Ortho Clinical Diagnostics Hits the Road with Interactive, Cross-Country Tour of XT Mobile Experience Center
Tour Brings Ortho's VITROS® XT 7600 Integrated System, Among Other Innovations in Diagnostics, to Laboratories Across the U.S.
New Availability of the VITROS® Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator to Help Labs Using Ortho's VITROS® ECi/ECiQ Immunodiagnostic System to Diagnose HIV Infection
FDA Approves Ortho Clinical Diagnostics VITROS® Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator for use on the VITROS® 5600 Integrated System
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced that the VITROS® Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator (VITROS® HIV Combo test) received approval from the U.S. Food and Drug Administration for use on Ortho's VITROS® 5600 Integrated System1.
FDA Clears VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics, Bringing Innovative New Approach to Clinical Lab Management
DIGITAL CHEMISTRY™ Technology Enables Powerful Data Intelligence, Operational Improvements and Other Enhancements in the Lab
Big Fish, Big Data and Blood Banks: Ortho Clinical Diagnostics to Demonstrate Comprehensive Middleware Solution, Host Customer Event at New England Aquarium During the 2018 AABB Annual Meeting
Customer Event to Highlight How Access to Information and Advances in Automation Can Improve Transfusion Medicine Operations